Omk1® eye drops
Omk1® is a sterile ophthalmic solution containing Citicoline 2% and high molecular weight hyaluronic acid 0,2%.
The product has been developed by Omikron Italia and it is covered by International Patent for glaucoma treatment (EU, USA and Japan).
Omk1® is registered in Italy and also in other 39 EU and extra-EU Countries as Medical Device with CE Marking with the following intended use: “Thanks to the presence of Citicoline and to its structural action on retinal ganglion cells, it is indicated as coadjuvant to antihypertensive therapy in Glaucomatous patients.”
Add-on treatment to hypotensive glaucoma therapy
to directly act on Retinal Ganglion Cells and on Optic Nerve head